Prognostic Value of VEGF in Patients Submitted to Percutaneous Coronary Intervention

Table 2

Angiographic and procedural data expressed as within-group percentage of the total number of patients (%) unless otherwise specified.

	All patients	ACS	Non-ACS
Multivessel disease (𝑛, %)	29, 31	19, 33	10, 29
Sintax Score^¥	9.5 (3.5–17.5)	15.5 (9.5–22.8)	4.0 (0–8.8)*
Intervened vessel (𝑛, %)
Left anterior descending artery	46, 51	29, 52	17, 50
Right coronary artery	28, 31	21, 38	7, 21
Left circumflex artery	11, 12	6, 11	5, 15
Left main artery	4, 4	0, 0	4, 12
Number of intervened lesions (𝑛, %)
1	52, 59	38, 68	14, 44
>1	20, 23	13, 23	7, 22
Lesion length (mm)^¥	22 (16–30)	22 (16–35)	16 (13–26)
Long lesion (>15 mm) (𝑛, %)	50, 77	36, 78	14, 74
Type B/C lesion (𝑛, %)	55, 86	41, 89	14, 78
Eccentric lesion (𝑛, %)	44, 75	29, 76	15, 71
Calcified lesion (𝑛, %)	17, 21	13, 25	4, 13
Thrombotic lesion (𝑛, %)	13, 16	12, 23	1, 3*
Stent type (𝑛, %)
DES	50, 63	34, 65	16, 57
BMS	15, 19	11, 22	4, 14

^¥Results expressed as median and interquartile (Q25–Q75).
*Significant difference to ACS (𝑃<0.05).